Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
5/30/2024 | $35.00 | Market Perform → Outperform | Northland Capital | |
11/21/2023 | $40.00 | Perform → Outperform | Oppenheimer | |
7/25/2023 | $40.00 | Market Perform | Northland Capital | |
6/29/2023 | Perform | Oppenheimer | ||
6/1/2023 | $24.00 → $50.00 | Neutral → Outperform | Wedbush | |
6/1/2023 | $30.00 | Buy → Neutral | DA Davidson | |
4/24/2023 | $14.00 | Peer Perform → Underperform | Wolfe Research | |
2/3/2023 | $30.00 | Buy | DA Davidson |
4 - C3.ai, Inc. (0001577526) (Issuer)
4 - C3.ai, Inc. (0001577526) (Issuer)
4 - C3.ai, Inc. (0001577526) (Issuer)
8-K - OneMedNet Corp (0001849380) (Filer)
10-Q - C3.ai, Inc. (0001577526) (Filer)
8-K - C3.ai, Inc. (0001577526) (Filer)
MINNEAPOLIS, Sept. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received an expected notice (the "First Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, due to the Company's failure to timely file its Form 10-Q for the fiscal quarter ended June 30, 2024 (the "Form 10-Q") with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq's continued listing requir
MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors. Mr. Golden is a Certified Public Accountant with more than 40 years of experience. Mr. Golden has served as the Managing Partner of Cohen, Bender & Golden LLP since 2015, where he provides consulting, accounting and tax services to middle market businesses and owners. Mr. Golde
Continued Accelerating Revenue Growth C3.ai, Inc. ("C3 AI," "C3," or the "Company") (NYSE:AI), the Enterprise AI application software company, today announced financial results for its fiscal first quarter ended July 31, 2024. "We had a solid start to the fiscal year, with rising demand for Enterprise AI driving our sixth consecutive quarter of accelerating revenue growth," said Thomas M. Siebel, Chairman and CEO, C3 AI. "C3 AI is the original Enterprise AI company. Our unwavering commitment to solving the most challenging problems in the enterprise has led us to what we believe are the highest levels of customer satisfaction in the industry." Fiscal First Quarter 2025 Financial Highl
TSLANVDAAICRWDQQQWAYGOOGLAAPLAMZNLOTData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
TSLACRWDNVDAWAYUPSAIGOOGLSPOTAMZNAAPLData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Northland Capital upgraded C3.ai from Market Perform to Outperform and set a new price target of $35.00
Oppenheimer upgraded C3.ai from Perform to Outperform and set a new price target of $40.00
Northland Capital initiated coverage of C3.ai with a rating of Market Perform and set a new price target of $40.00
SC 13G - OneMedNet Corp (0001849380) (Subject)
SC 13G/A - C3.ai, Inc. (0001577526) (Subject)
SC 13G - C3.ai, Inc. (0001577526) (Subject)
MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors. Mr. Golden is a Certified Public Accountant with more than 40 years of experience. Mr. Golden has served as the Managing Partner of Cohen, Bender & Golden LLP since 2015, where he provides consulting, accounting and tax services to middle market businesses and owners. Mr. Golde
MONTREAL and CHARLOTTE, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (NASDAQ:MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Joseph Papa to its Board of Directors ("Board"), effective September 3, 2024. Mr. Papa is a renowned pharmaceutical and healthcare leader, with more than 35 years of experience navigating companies through periods of rapid growth, transformation, and strategic M&A transactions, including as former Chairman and CEO of Bausch + Lomb, Bausch Health and Perrigo and as a director of SparingVision and Candel Therapeutics. He brings bro
C3 AI (NYSE:AI), the Enterprise AI application software company, is proud to announce the appointment of Kevin McCarthy, the immediate past Speaker of the House, to its advisory board. Mr. McCarthy will play a pivotal role in guiding C3 AI's expansion of AI solutions among all levels of government, as well as fostering relationships with allied nations. "Kevin McCarthy's unparalleled experience in public service and his deep understanding of the needs of government at all levels will be invaluable to C3 AI," said Thomas M. Siebel, Chairman and CEO, C3 AI. "His insight will enhance our ability to deliver transformative AI solutions to our customers in law enforcement, property value assess
Continued Accelerating Revenue Growth C3.ai, Inc. ("C3 AI," "C3," or the "Company") (NYSE:AI), the Enterprise AI application software company, today announced financial results for its fiscal first quarter ended July 31, 2024. "We had a solid start to the fiscal year, with rising demand for Enterprise AI driving our sixth consecutive quarter of accelerating revenue growth," said Thomas M. Siebel, Chairman and CEO, C3 AI. "C3 AI is the original Enterprise AI company. Our unwavering commitment to solving the most challenging problems in the enterprise has led us to what we believe are the highest levels of customer satisfaction in the industry." Fiscal First Quarter 2025 Financial Highl
C3 AI (NYSE:AI), the Enterprise AI application software company, today announced it will issue its financial results for the fiscal first quarter, which ended July 31, 2024, following the close of the U.S. markets on Wednesday, September 4, 2024. C3 AI will host a conference call and webcast to discuss the financial results. The conference call will begin at 2:00 p.m. PDT / 5:00 p.m. EDT on September 4, 2024. Analysts and investors may participate in the question-and-answer session. Conference Call Details Date: Wednesday, September 4, 2024 Time: 2:00 p.m. Pacific Standard Time To access the conference call via a dial-in number and personalized PIN code, participants should regist
Increasing Revenue Growth. Raising Guidance. Growth Accelerates for Fifth Consecutive Quarter, Record Federal Growth Subscription Revenue for the Fourth Quarter Increased 41% Year-Over-Year C3.ai, Inc. ("C3 AI," "C3," or the "Company") (NYSE:AI), the Enterprise AI application software company, today announced financial results for its fiscal fourth quarter and full fiscal year ended April 30, 2024. "We finished a strong quarter and closed out a huge year for C3 AI. This was our fifth consecutive quarter of accelerating revenue growth. Our fourth quarter revenue grew by 20% year-over-year to $86.6 million, exceeding the top end of our guidance. Our full year revenue grew by 16% to $3